Company: DAWN
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013462
Chunk: 54

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 54
---
. We do not provide, and have no obligation to provide, any executive officer, including any NEO, with a “gross-up” or other reimbursement payment for any tax liability that he or she might owe because of the application of Section 280G, 4999, or 409A of the Internal Revenue Code. 41 TABLE OF CONTENTS REPORT OF THE COMPENSATION COMMITTEE This report of the Compensation Committee is required by the SEC and, in accordance with the SEC’s rules, will not be deemed to be part of or incorporated by reference by any general statement incorporating by reference this Proxy Statement into any filing under the Securities Act or under the Exchange Act, except to the extent that we specifically incorporate this information by reference, and will not otherwise be deemed “soliciting material” or “filed” under either the Securities Act or the Exchange Act. Our Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with management and based on such review and discussions, the compensation committee recommended to our board of directors that the Compensation Discussion and Analysis be included in this Proxy Statement. Submitted by the Compensation Committee Natalie Holles, Chair William Grossman Garry Nicholson 42

TABLE OF CONTENTS

Executive Compensation Tables The following table provides information concerning compensation awarded to, earned by or paid to each of our NEOs for all services rendered in all capacities during the years ended December 31, 2024, 2023 and 2022, respectively. Summary Compensation Table

| Name and Principal Position                             |      |     | Fiscal 
   Year |         |     |  Salary 
     ($) |           |     |    Option 
 Awards(1) |           |     |     Stock 
    Awards 
    ($)(2) |         |     |     Non-Equity 
 Incentive Plan 
   Compensation 
         ($)(3) |        |     |          All 
        Other 
 Compensation 
       ($)(4) |           |     |     Total 
       ($) |
| Jeremy Bender(5)                                        
 Chief Executive Officer and President                   |      |     |   2024 |         |     | 680,000 |           |     | 2,664,697 |           |     | 2,700,280 |         |     |        501,800 |        |     |       13,800 |           |     | 6,560,577 |
|                                                         | 2023 |     |        |